John Ryals, PhD, President and CEO of Metabolon, explains how metabolites can be a powerful precision medicine ally, for both researchers and clinicians
Toby Hannam from Incisive Health reflects on a Festival of Genomics notable for the absence of a leading politician
Dr Keith Bradnam reports on what the genomics revolution means for routine medical care, and for cancer research in particular
Nathan Harris of Thermo Fisher Scientific explains how growing levels of automation in molecular laboratories are having an incredible impact on research
Our first Front Line Genomics Roundtable discussion explores what needs to be done at a practical level to integrate genomics into everyday medical practice
We speak to Clive Brown, CTO of Oxford Nanopore, about the “CliveOme”: his latest project to entirely self-sequence his own genome
Sarah Teichmann, Head of Cellular Genetics at the Wellcome Trust Sanger Institute, tells us about an ambitious new initiative to map all human body cells
Merja Mehto from Thermo Fisher Scientific tells us about how we can automate sample purification in the lab without giving up valuable bench space
The debate over racial bias in genomics rages on, but as FLG managing editor Carl Smith asks, are we avoiding a larger problem?
Genomic databases have a problem with racial bias, according to new research. Manuel Corpas has been looking for the same patterns in personal genomics
Straight out of San Diego, California, comes next-generation mapping for structural variations in the genome
What underlies disruptive scientific advancement? Marc Hogenbirk of Bluebee makes the case that many advances are driven by the availability of data
Luke Hickey, senior Director of Human Biomedical Sequencing at PacBio, explores the discoveries that teach us a little more about genomes and genetic code
Paldeep Atwal, Medical Director at the Mayo Clinic takes a look at what genomic medicine actually looks like, and what will get us there
Upon completion of the human genome project we were promised a change in the way our drugs were developed. How has the genomic era changed drug development?